• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HUO Yanfei,LU Changfei,XIE Yanjun,XU Lili,CHANG Hong,SUN Chunxiao,LI Xia.Analysis of ADR Reports and Risk Factors of 285 Cases of Arsenious Acid Sodium Chloride Injection[J].Journal Of Pharmaceutical Research,2024,43(7):723-728[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3209times   Download 3391次 QR Code for this article
Scan with your phone!
285例亚砷酸氯化钠注射液不良反应报告及风险因素分析
霍艳飞,路长飞,谢彦军,许莉莉,常虹,孙春晓,李霞
Font:Larger+|Default|Smaller-
(山东省药品不良反应监测中心,山东 济南 250014)
摘要:
目的 研究亚砷酸氯化钠注射液药品不良反应(ADR)特点及风险因素,为促进临床合理用药提供参考。方法 检索山东省药品不良反应监测系统数据库,对2005年1月1日至2022年12月31日收集的285例亚砷酸氯化钠注射液ADR报告进行回顾性分析。结果 285例报告中,男性患者占比高于女性;从年龄上看,45~64岁人群占比较高;不良反应多发生在用药2周内;ADR主要累及肝胆、胃肠、全身性等多系统和器官损害,QT间期延长、发热、胸闷等风险在说明书中均未提及。结论 药品上市许可持有人需加强上市后药品安全性研究与评价,完善说明书安全性内容;指导临床合理用药,严格按照说明书要求使用;加强老年患者用药监测,特别是肝胆系统、心血管系统的相关指标,保障公众用药安全。
关键词:  亚砷酸氯化钠注射液  药品不良反应  安全用药
DOI:10.13506/j.cnki.jpr.2024.07.018
基金项目:
Publication Date:July 25, 2024
Analysis of ADR Reports and Risk Factors of 285 Cases of Arsenious Acid Sodium Chloride Injection
HUO Yanfei,LU Changfei,XIE Yanjun,XU Lili,CHANG Hong,SUN Chunxiao,LI Xia
(Shandong Center for Adverse Drug Reaction Monitoring,Jinan 250014, China)
Abstract:
Objective To study the characteristics and influencing factors of adverse drug reactions (ADR) of arsenious acid sodium chloride injection, and provide reference for promoting clinical rational drug use.Methods The ADR reports of 285 cases of arsenious acid sodium chloride injection collected from January 1st, 2005 to December 31st, 2022 were analyzed retrospectively by searching the database of ADR monitoring system in Shandong Province.Results In 285 cases, the proportion of male patients was higher than that of female patients. People aged 45 ~ 64 account for a relatively high proportion; Adverse reactions mostly occurred within 2 weeks of medication. ADR mainly involves hepatobiliary, gastrointestinal, systemic and other multi-system and organ damages, and the risks of QT interval prolongation, fever and chest tightness are not mentioned in the instructions. Conclusion Drug marketing license holders should strengthen the research and evaluation of drug safety after marketing, improve the safety content of the instructions; Guide clinical rational medication and strictly follow the instructions for use; Strengthen medication monitoring for elderly patients, especially related indicators of the hepatobiliary system and cardiovascular system, and ensure the safety of drug use by the public.
Key words:  Arsenious Acid Sodium Chloride Injection  Adverse drug reaction(ADR)  Safe medication
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.